ClearPoint Neuro, Inc. Common Stock (NASDAQ: CLPT) last traded at $10.48, down 0.10% on the session. The quote above updates while this page is open; the figures below are drawn from ClearPoint Neuro, Inc. Common Stock’s own filings and are restated only when a new one is published.
ClearPoint Neuro, Inc. Common Stock trades on NASDAQ under the ticker CLPT. Its market capitalisation is $319.68 million.
Valuation measures for ClearPoint Neuro, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $319.68M |
|---|---|
| Enterprise value | $366.29M |
| Price / sales | 7.56 |
| Price / book | 29.67 |
| Beta | 1.69 |
Trailing-twelve-month figures tagged in ClearPoint Neuro, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $42.28M |
|---|---|
| Net income (TTM) | -$34.57M |
| EPS (TTM) | -$1.17 |
| Gross margin | 62.61% |
| Operating margin | -73.42% |
| Return on equity | -320.77% |
| Cash | $29.36M |
Range and volume for CLPT over the past 52 weeks.
| 52-week high | $28.10 |
|---|---|
| 52-week low | $8.27 |
| Volume | 410.0K |
| Average volume | 639.3K |
| Previous close | $10.49 |
Invest a chosen dollar amount in ClearPoint Neuro, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CLPT.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.